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Background: Cardiovascular disease is the leading cause of death in end-stage
renal disease (ESRD) patients and is strongly associated with malnutrition.
The mechanism of malnutrition is not clear but hypermetabolism is suggested
to contribute to cardiac cachexia. Methods: In this study, we examined factors
relating to resting energy expenditure (REE) and its association with clinical
outcomes of ESRD patients. This prospective study consisted of 251 CAPD
patients (M/F: 130/121, mean age 55 years), with REE measured at baseline
using indirect calorimetry together with other clinical, nutritional and dialysis
parameters. Results: Fat-free edema-free body mass (FFM) adjusted REE was
39.1 ( 9.6 and 40.1 ( 9.0 kcal/kg/day for men and women, respectively (p =
0.391). Using multiple regression analysis, FFM-adjusted REE was negatively
associated with residual glomerular filtration rate (GFR) (p < 0.001) and serum
albumin (p = 0.046) and positively associated with diabetes (p = 0.002),
cardiovascular disease (CVD) (p = 0.009) and C-reactive protein (CRP) (p =
0.009). During the prospective follow-up of 28.7 ( 14.3 months, 14.3% of
patients in the lower tertile vs 42.4% and 47.6% of patients in middle and
upper tertiles died (p < 0.0001). Log-rank test showed that the overall survival
(p < 0.0001) and cardiovascular event-free survival (p = 0.0003) decreased
across the three tertiles of increasing REE. Adjusting for age, gender, diabetes
and CVD, patients in the upper and middle tertiles showed a 4.19 fold (95%
CI, 2.15 to 8.16; p < 0.001) and a 2.90 fold (95% CI, 1.49, 5.63; p = 0.002)
respective increase in the risk of all-cause mortality than those in the lower
tertile. When additional adjustment was made for CRP, patients in the upper
and middle tertiles showed a 3.89 fold (95% CI, 2.99 to 7.60) and 2.75 fold
(95% CI, 1.42 to 5.34) increased risk of mortality, respectively than those in
the lower tertile. Further controlling for serum albumin slightly reduced the
risk of mortality for patients in the upper [hazard ratio (HR), 3.38, 95% CI,
1.71 to 6.67] and middle tertiles (HR, 2.55, 95% CI, 1.31 to 4.87) compared to
the lower tertile. The significance of REE in predicting mortality was most
substantially reduced when additional adjustment was made for residual GFR.
Conclusions: Resting hypermetabolism is associated with increased mortality
and cardiovascular death in CAPD patients and is partly related to its close
correlation with loss of residual kidney function, cardiovascular disease,
inflammation and malnutrition. Our data suggests resting hypermetabolism
should be regarded as a component of the malnutrition, inflammation and
atherosclerosis (MIA) syndrome in CAPD patients.
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Background: Cytokine transforming growth factor (TGF) is involved in
regulation of tissue repair after injury. Recently, TGF–`1 codon 10 gene
polymorphism has been shown to be associated with circulating TGF-` levels.
Donor TGF-`1 genomics have also been found to associate with acute rejection.
We tested whether recipient TGF-`1 genotype polymorphism was predictive
of renal allograft function decline. Methods: The study population consisted
of 129 consecutive cadaveric or living related renal transplant recipients at our
center between 1985 and 2001. The recipient TGF-`1 genotype polymorphism
was determined from peripheral blood leukocytes DNA. The primary end point
was rate of glomerular filtration rate decline between the first year and the
third year of transplant. Results: Baseline glomerular filtration rate as estimated
by MDRD Study equation at one year measured 50 ( 17 mL/min/1.73 m2. At
the end of the 3-year follow-up period, 52 patients (40%) experienced biopsy-
confirmed acute rejections. Frequency and severity of allograft rejection did
not differ with TGF-` genotypes. However, the decline in glomerular filtration
rate was significantly greater in Leu/Leu (TT) than Leu/Pro (CT) recipients,
6.3 ( 16.9 mL/min/1.73 m2 versus 0.1 ( 10.2 mL/min/1.73 m2, p = 0.04.
Conclusions: Our results demonstrate that recipient TGF-`1 codon 10 Leu/
Leu homozygosity is a potential risk factor of kidney allograft function decline.
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index (SRI) for urea
Y.L. Cheng, C.U. Yung, S.K. Chau, Y.T. Tsui, K.Y. Tsang, K.Y. Chung, C.K.
Wong, F.S.Y. Wong, A.W.Y. Yu
Renal Unit, Alice Ho Miu Ling Nethersole Hospital, Hong Kong.
Background: SRI has been considered to be a more precise gauge of dialysis
dose. The use of simplified SRI (sSRI or SRI without considering facet of
intradialytic urea nitrogen generation) has also been proposed because data
pertaining to urea generation are not always at hand. Recently, we modified
the equation of urea reduction ratio and the mURR obtained correlates very
well with the single-pool Kt/V. Conceptually, mURR and sSRI are closely
related. Methods: In the present study, we attempted to test the relationship
between mURR, SRI and sSRI. Forty-six stable maintenance HD patients were
studied. SRI and sSRI were calculated with urea distribution volume derived
by direct dialysis quantification method with unequilibrated postdialysis blood
sample. Total urea nitrogen removed during dialysis was estimated by Ing’s
partial dialysate collection method. Results:
mURR sSRI SRI
Mean ( SD 77.5 ( 5.9% 77.4 ( 6.1% 73.4 ( 5.7%
Paired t test p = 0.523 p = 0.0001
r value 0.986 0.989
p < 0.0001 p < 0.0001
Mean differences 0.1 % 4.1 %
Limits of agreement –2.0–2.2% 2.3–5.8%
Conclusions: Our data suggest there was no statistical difference between
mURR and sSRI values. Moreover, mURR demonstrated good correlation with
SRI, although, similar as sSRI, mURR overestimated the SRI values by
approximately 4%. Our results suggest mURR is an excellent estimate of sSRI
and it circumvents problems associated with dialysate collection in the
determination of sSRI.
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Background: Vascular cell adhesion molecule-1 (VCAM-1) is involved in
leukocyte-endothelial cell interaction and plays a pivotal role in inflammation.
Studies have shown it to be elevated in chronic renal failure. Whether it
contributes to excessive mortality in these patients remains uncertain. Objective:
This study examined the associations of circulating sVCAM-1 with different
clinical and biochemical parameters and its relationships with mortality and
cardiovascular events in peritoneal dialysis patients. Methods: Fasting blood
was collected in 160 chronic peritoneal dialysis patients (82 men and 78 women,
age 57 ( 11 years) at study baseline for measurement of serum sVCAM-1
together with C-reactive protein (CRP), homocysteine, albumin and blood
hemoglobin. At the same time, indices of dialysis adequacy were measured and
echocardiography was performed Patients were prospectively followed up for
35 ( 16 months. Results: Circulating sVCAM-1 was markedly elevated (1,649
( 473 ng/mL) in our peritoneal dialysis patients and showed negative correlation
with residual glomerular filtration rate (GFR) (p < 0.001) but positive correlation
with left ventricular mass index (p = 0.026) and dialysis duration (p = 0.031).
Using Kaplan-Meier analysis, the overall survival at 2 years was 96.2%, 75.2%
and 50.6% respectively, for patients in the lower, middle and upper tertiles of
sVCAM-1 (p < 0.0001). Fatal and non-fatal cardiovascular event-free survival
was 58.2%, 56.9% and 19.4% for patients in the lower, middle and upper tertiles,
respectively (p < 0.0001). Using Cox regression analysis with adjustment for
confounding covariates, every 100 ng/mL increase in sVCAM-1 was associated
with a 7% (95% CI, 1.02, 1.13) and a 5% (95% CI, 1.00, 1.10) respective increase
in the risk of death and fatal and non-fatal cardiovascular events, but the
significance was lost when additional adjustment was made for residual GFR.
Furthermore, patients having both sVCAM-1 and CRP elevated * 50th percentile
were associated with the greatest death and fatal and non-fatal cardiovascular
event rate when compared to those with either CRP or sVCAM-1 elevated
* 50th percentile. Conclusions: Circulating sVCAM-1 shows an important link
with residual renal function and cardiac hypertrophy in CAPD patients.
Furthermore, the relationships of sVCAM-1 with mortality and fatal and non-
fatal cardiovascular events in CAPD patients appear to be largely mediated via
its association with residual renal function. Further study is needed to explore
possible mechanistic links between inflammation, soluble adhesion molecules,
residual renal function and cardiac hypertrophy in CAPD patients.
